Home » Psychology news » Earlier alzheimer’s diagnosis may be possible with new imaging compound
Earlier alzheimer’s diagnosis may be possible with new imaging compound
November 2, 2016 by NewsBot
Researchers have developed a chemical compound that detects the Alzheimer’s protein amyloid beta better than current FDA-approved agents. The compound potentially could be used in brain scans to identify the signs of Alzheimer’s early, or to monitor response to treatment.
